925 followers
New article: A Phase 1 Study of IRX195183, a RARα-Selective CYP26 Resistant Retinoid, in Patients With Relapsed or Refractory AML. https://t.co/8J3TrificW #AML #leusm #hematology https://t.co/uq1U5xuDPg
New article: A Phase 1 Study of IRX195183, a RARα-Selective CYP26 Resistant Retinoid, in Patients With Relapsed or Refractory AML. https://t.co/8J3TrificW #AML #leusm #hematology https://t.co/uq1U5xuDPg